Home Cart Sign in  
Chemical Structure| 315705-75-0 Chemical Structure| 315705-75-0

Structure of JNJ0966
CAS No.: 315705-75-0

Chemical Structure| 315705-75-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

JNJ0966 is a selective inhibitor of MMP-9 zymogen (IC50 = 440nM) that inhibits subsequent generation of the catalytically active enzyme. It showed no effect on the catalytic activity of MMP-1, MMP-2, MMP-3, MMP-9, or MMP-14, and did not inhibit the activation of MMP-2 zymogen.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of JNJ0966

CAS No. :315705-75-0
Formula : C16H16N4O2S2
M.W : 360.45
SMILES Code : CC(NC1=NC(C)=C(C2=CSC(NC3=CC=CC=C3OC)=N2)S1)=O
MDL No. :MFCD02045222
InChI Key :ZADCDCMLLGDCRM-UHFFFAOYSA-N
Pubchem ID :1117189

Safety of JNJ0966

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat lens epithelial cells (LECs) 20 µM 48 hours To validate the efficacy of JNJ0966 in inhibiting MMP9 and preventing TGF-β-induced epithelial-mesenchymal transition PMC8584335
HT1080 cells 1.0 μM 24 hours To evaluate the effect of JNJ0966 on HT1080 cell invasion through a Matrigel extracellular matrix layer, results showed JNJ0966 significantly inhibited cell invasion PMC5663893

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Experimental autoimmune encephalomyelitis (EAE) model Oral gavage 10 mg/kg and 30 mg/kg Twice daily until day 17 of the study To evaluate the therapeutic effect of JNJ0966 in the EAE model, results showed JNJ0966 significantly reduced disease severity PMC5663893

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.87mL

2.77mL

1.39mL

27.74mL

5.55mL

2.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories